CBLL Strangle Strategy
CBLL (CeriBell, Inc.), in the Healthcare sector, (Medical - Devices industry), listed on NASDAQ.
CeriBell, Inc. specializes in pioneering artificial intelligence (AI)-powered electroencephalography (EEG) solutions designed for the immediate diagnosis and treatment of neurological conditions directly at the patient's bedside. The company's primary offering is the Ceribell System, an innovative, on-site EEG platform engineered to fulfill crucial, previously unmet requirements for patients in urgent medical environments. Beyond the core system, CeriBell also provides single-use EEG headbands and compact, battery-powered recording devices. Originally established in 2014 as Brain Stethoscope, Inc., the company underwent a name change to CeriBell, Inc. in August 2015. Its headquarters are located in Sunnyvale, California.
CBLL (CeriBell, Inc.) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $758.1M, a beta of 0.84 versus the broader market, a 52-week range of 10.85-24.33, average daily share volume of 304K, a public-listing history dating back to 2024, approximately 281 full-time employees. These structural characteristics shape how CBLL stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.84 places CBLL roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a strangle on CBLL?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current CBLL snapshot
As of June 30, 2026, spot at $19.50, ATM IV 100.60%, IV rank 23.64%, expected move 28.84%. The strangle on CBLL below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this strangle structure on CBLL specifically: CBLL IV at 100.60% is on the cheap side of its 1-year range, which favors premium-buying structures like a CBLL strangle, with a market-implied 1-standard-deviation move of approximately 28.84% (roughly $5.62 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CBLL expiries trade a higher absolute premium for lower per-day decay. Position sizing on CBLL should anchor to the underlying notional of $19.50 per share and to the trader's directional view on CBLL stock.
CBLL strangle setup
The CBLL strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CBLL near $19.50, the first option leg uses a $20.48 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CBLL chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CBLL shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $20.48 | N/A |
| Buy 1 | Put | $18.53 | N/A |
CBLL strangle risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
CBLL strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on CBLL. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use strangle on CBLL
Strangles on CBLL are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the CBLL chain.
CBLL thesis for this strangle
The market-implied 1-standard-deviation range for CBLL extends from approximately $13.88 on the downside to $25.12 on the upside. A CBLL long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current CBLL IV rank near 23.64% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on CBLL at 100.60%. As a Healthcare name, CBLL options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CBLL-specific events.
CBLL strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CBLL positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CBLL alongside the broader basket even when CBLL-specific fundamentals are unchanged. Always rebuild the position from current CBLL chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on CBLL?
- A strangle on CBLL is the strangle strategy applied to CBLL (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With CBLL stock trading near $19.50, the strikes shown on this page are snapped to the nearest listed CBLL chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are CBLL strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the CBLL strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 100.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a CBLL strangle?
- The breakeven for the CBLL strangle priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CBLL market-implied 1-standard-deviation expected move is approximately 28.84%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on CBLL?
- Strangles on CBLL are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the CBLL chain.
- How does current CBLL implied volatility affect this strangle?
- CBLL ATM IV is at 100.60% with IV rank near 23.64%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.